Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: €0.25 M
• Last 3 months FTD volume: €1.59 M
• Last year FTD volume: €1.59 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Seagen SGEN	N/A	€3.02 M	🇺🇸 USA
Agenus AGEN	N/A	€1.84 M	🇺🇸 USA
Emergent BioSolutions EBS	€1.1 M	€6.08 M	🇺🇸 USA
Amgen AMGN	€37.13 M	€0.21 B	🇺🇸 USA
Pfizer PFE	€21.73 M	€0.33 B	🇺🇸 USA
GlaxoSmithKline GSK	€94.71 M	€0.14 B	🇬🇧 UK
Titan Pharmaceuticals TTNP	€0.1 M	€1.32 M	🇺🇸 USA